Search research articles
Contact Us
Filters
Showing results (241-250 of 336) with videos related to
Page
of 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 5, 2005
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients
Lynn G Dressler, Donald A Berry, Gloria Broadwater, et al.
The New England Journal of Medicine
|
October 12, 2007
HER2 and response to paclitaxel in node-positive breast cancer
Daniel F Hayes, Ann D Thor, Lynn G Dressler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2009
Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897
Christine B Ambrosone, William E Barlow, Wanda Reynolds, et al.
Biopreservation and Biobanking
|
August 10, 2011
Biospecimen Reporting for Improved Study Quality
Helen M Moore, Andrea Kelly, Scott D Jewell, et al.
Molecular Oncology
|
May 15, 2016
Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance
Costanza Paoletti, Jose M Larios, Maria C Muñiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2015
Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy
Cesar A Santa-Maria, Amanda Blackford, Anne T Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Catherine Van Poznak, Mark R Somerfield, Robert C Bast, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer
Antonio C Wolff, Ann A Lazar, Igor Bondarenko, et al.
Breast Cancer Research and Treatment
|
November 6, 2015
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover
Steffi Oesterreich, N Lynn Henry, Kelley M Kidwell, et al.
Cancer Research Communications
|
June 28, 2023
Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment
Aki Morikawa, Jinju Li, Peter Ulintz, et al.
Page
of 34
Search research articles
Search
Showing results (241-250 of 336) with videos related to
Sort By:
Page
of 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 5, 2005
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients
Lynn G Dressler, Donald A Berry, Gloria Broadwater, et al.
The New England Journal of Medicine
|
October 12, 2007
HER2 and response to paclitaxel in node-positive breast cancer
Daniel F Hayes, Ann D Thor, Lynn G Dressler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2009
Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897
Christine B Ambrosone, William E Barlow, Wanda Reynolds, et al.
Biopreservation and Biobanking
|
August 10, 2011
Biospecimen Reporting for Improved Study Quality
Helen M Moore, Andrea Kelly, Scott D Jewell, et al.
Molecular Oncology
|
May 15, 2016
Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance
Costanza Paoletti, Jose M Larios, Maria C Muñiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2015
Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy
Cesar A Santa-Maria, Amanda Blackford, Anne T Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Catherine Van Poznak, Mark R Somerfield, Robert C Bast, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer
Antonio C Wolff, Ann A Lazar, Igor Bondarenko, et al.
Breast Cancer Research and Treatment
|
November 6, 2015
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover
Steffi Oesterreich, N Lynn Henry, Kelley M Kidwell, et al.
Cancer Research Communications
|
June 28, 2023
Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment
Aki Morikawa, Jinju Li, Peter Ulintz, et al.
Page
of 34